Status:
COMPLETED
Randomized Controlled Trial to Evaluate the Impact of ZYN Nicotine Pouch Products on Cigarette Usage and BoExp in Adult Smokers Over a 12-week Period
Lead Sponsor:
Swedish Match AB
Conditions:
Tobacco Use
Eligibility:
All Genders
22-65 years
Phase:
NA
Brief Summary
To verify whether unrestricted access to flavored products is likely to lead to greater reductions in combustible cigarette smoking and decreased exposure to smoking related toxicants.
Detailed Description
US adult smokers will be randomized into three groups (Group I: (control) continue smoking their usual brand of CC; Group II: provided with tobacco flavor and unflavored options of ZYN; Group III: pro...
Eligibility Criteria
Inclusion
- Healthy adult smokers 22 to 65 years of age (inclusive) at screening.
- Smokes an average of at least 10 commercially available cigarettes per day for the last 12 months.
- Interested in switching from combustible cigarettes to nicotine pouch products.
Exclusion
- Participants of childbearing potential (CBP) who are breast-feeding or have a positive pregnancy test.
- Participants who currently use nicotine pouches.
- Participants with known heart disease or medical condition that may adversely affect participant safety
Key Trial Info
Start Date :
July 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2024
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06568900
Start Date
July 31 2023
End Date
August 19 2024
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rose Research Center
Raleigh, North Carolina, United States, 27617